Cannabis

Evidence for medicinal use of cannabis organized into the following categories: Pain Management, Safety, Use with Other Medications, Misuse/Abuse, Harm, and Cannabis use for Specific Conditions and Populations.

Basic overview of common cannabis plants and products, as well as methods of consumption and approaches to harm reduction.
(Canadian Public Health Association, 2018)

Evidence summary about the potential risks and benefits to health from the use of recreational and medicinal cannabis.
(Royal Society of New Zealand, 2019)

This cancer information summary provides an overview of the use of Cannabis and its components as a treatment for people with cancer-related symptoms caused by the disease itself or its treatment.
*Use left menu to navigate topic sections.
(National Cancer Institute, 2021)

Provides an overview of edible cannabis products, cannabis extracts and topical cannabis products. Outlines the differences among these products, including their use and effects.
(Canadian Centre on Substance Use and Addiction, 2019)

Consolidated overviews of the state of medicinal cannabis across various clinical and research areas.

Evidence and resources on the use of cannabis for medical purposes.
(Canadian Agency for Drugs and Technologies in Health (CADTH))

(Canadian Nurses Association, 2018)

See Section 3.0 regarding Dosing, 4.0 regarding Potential Therapeutic Uses, and 7.0 regarding Adverse Effects.
(Health Canada, 2018)

A CADTH rapid response report, summary with critical appraisal. (2019)

(RXFiles, 2019)

DynaMed Plus
Access:
[Online access at Dalhousie University]

RxTx
[Online access at Nova Scotia Health Library Services]
[Online access at Dalhousie University]
*In the RxTx search bar, copy and paste the phrase Cannabis CPhA Monograph and then select it from the list.

[Online access at Nova Scotia Health Library Services]
*Also includes section on Effectiveness, Adverse Effects and Interactions.

[Online access at Nova Scotia Health Library Services]
*Also includes section on Effectiveness, Adverse Effects and Interactions.

[Online access at Nova Scotia Health Library Services]
[Online access at Dalhousie University]
*Enter "cannabis" in the main search box

Cannabis use is higher in young people than any other age group. This youth version of Canada’s Lower-Risk Cannabis Use Guidelines (LRCUG) was developed for youth, by youth.
(Canadian Research Initiative in Substance Misuse (CRISM) & Centre for Addiction and Mental Health (CAMH), 2018)

(Canadian Research Initiative in Substance Misuse (CRISM) & Centre for Addiction and Mental Health (CAMH), 2019)

(Nova Scotia College of Nursing, published July 2022)

(College of Family Physicians of Canada, 2021)

(Canadian Research Initiative in Substance Misuse (CRISM) & (Canadian Mental Health Association (CMHA), 2018)

(Canadian Family Physicians, 2018)

Cannabis resources to support clinical practice.
(Canadian Nurses Association)

(Nova Scotia College of Pharmacists, 2018)

(New Brunswick College of Pharmacists, 2018)

(Canadian Federation of Medical Students, 2018)

(College of Physicians & Surgeons of Nova Scotia, Updated December 2020)

Medication Management Policy and Procedure: Patient’s Own Medical Cannabis. IWK Health Centre (2018)

Spindle, T. R., Cone, E. J., Schlienz, N. J., Mitchell, J. M., Bigelow, G. E., Flegel, R., ... & Vandrey, R. (2018). Acute effects of smoked and vaporized cannabis in healthy adults who infrequently use cannabis: a crossover trial. JAMA network open, 1(7), e184841-e184841.

Whiting, P.F., Wolff, R.F., Deshpande, S., Di Nisio, M., Duffy, Steven, H., Adrian V., . . . & Vascular Medicine. (2015). Cannabinoids for medical use: a systematic review and meta-analysis. JAMA, 313(24), 2456-2473.

Stockings, E., Campbell, G., Hall, W. D., Nielsen, S., Zagic, D., Rahman, R., ... & Degenhardt, L. (2018). Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies. Pain, 159(10), 1932-1954.

Kafil, T. S., Nguyen, T. M., MacDonald, J. K., & Chande, N. (2018). Cannabis for the treatment of Crohn's disease. Cochrane Database of Systematic Reviews, (11).

Kafil, T. S., Nguyen, T. M., MacDonald, J. K., & Chande, N. (2018). Cannabis for the treatment of ulcerative colitis. Cochrane Database of Systematic Reviews, (11).

Lattanzi, S., Brigo, F., Trinka, E., Zaccara, G., Cagnetti, C., Del Giovane, C., & Silvestrini, M. (2018). Efficacy and safety of cannabidiol in epilepsy: a systematic review and meta-analysis. Drugs, 1-14.

Russell, C., Rueda, S., Room, R., Tyndall, M., & Fischer, B. (2018). Routes of administration for cannabis use – basic prevalence and related health outcomes: a scoping review and synthesis. International Journal of Drug Policy, 52, 87-96.

Koppel, B. S., Brust, J. C., Fife, T., Bronstein, J., Youssof, S., Gronseth, G., & Gloss, D. (2014). Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology, 82(17), 1556-1563.

Mouhamed, Y., Vishnyakov, A., Qorri, B., Sambi, M., Frank, S. S., Nowierski, C., … Szewczuk, M. R. (2018). Therapeutic potential of medicinal marijuana: an educational primer for health care professionals. Drug, Healthcare and Patient Safety, 10, 45–66. https://doi.org/10.2147/DHPS.S158592